Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -69.85x is 299% below its 1-year average of -17.52x, near the low end of its 1-year range (-69.85x–-12.79x).
Reported quarterly interest coverage; no daily interpolation. Q2 FY2025 (2025-06-30): -19.60x.
INTEREST COVERAGE RATIO
-69.85x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-995.69%
vs the sector median at left
Crescent Biopharma, Inc.
Market Cap
$504.04M
Interest Coverage Ratio
-69.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$503.93M
Interest Coverage Ratio
-192.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$502.81M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$500.52M
Interest Coverage Ratio
28.21x
TTM Avg
19.43x
3Y Avg
14.40x
5Y Avg
14.40x
Market Cap
$498.52M
Interest Coverage Ratio
-99.49x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$516.76M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$519.25M
Interest Coverage Ratio
-57.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Crescent Biopharma, Inc. (CBIO) | $504.04M | -69.85x | N/A | N/A | N/A |
| Allogene Therapeutics, Inc. (ALLO)vs › | $503.93M | -192.50x | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $502.81M | N/A | N/A | N/A | N/A |
| 908 Devices Inc. (MASS)vs › | $505.87M | N/A | N/A | N/A | N/A |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.52M | 28.21x | 19.43x | 14.40x | 14.40x |
| Oculis Holding AG (OCS)vs › | $498.52M | -99.49x | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $516.76M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $519.25M | -57.76x | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $486.01M | -1.91x | N/A | N/A | N/A |
| Immix Biopharma, Inc. (IMMX)vs › | $524.43M | N/A | N/A | N/A | N/A |
Interest Coverage
-69.8x
Debt/Equity
0.01
Current Ratio
9.66
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-06-30 | -19.60x |
| 2025-03-31 | -12.79x |
| 2024-12-31 | -20.18x |
